Back to Search Start Over

Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

Authors :
Adeera Levin
Marcello Tonelli
Joseph Bonventre
Josef Coresh
Jo-Ann Donner
Agnes B Fogo
Caroline S Fox
Ron T Gansevoort
Hiddo J L Heerspink
Meg Jardine
Bertram Kasiske
Anna Köttgen
Matthias Kretzler
Andrew S Levey
Valerie A Luyckx
Ravindra Mehta
Orson Moe
Gregorio Obrador
Neesh Pannu
Chirag R Parikh
Vlado Perkovic
Carol Pollock
Peter Stenvinkel
Katherine R Tuttle
David C Wheeler
Kai-Uwe Eckardt
Dwomoa Adu
Sanjay Kumar Agarwal
Mona Alrukhaimi
Hans-Joachim Anders
Gloria Ashuntantang
Shakti Basnet
Aminu K. Bello
Worawon Chailimpamontree
Ricardo Correa-Rotter
Jonathan Craig
Walter G. Douthat
Harold I. Feldman
Mohammad Reza Ganji
Guillermo Garcia-Garcia
Mohammed Benghanem Gharbi
David C. Harris
Vivekanand Jha
David W. Johnson
Rumeyza Kazancioglu
Robyn Langham
Zhi-Hong Liu
Ziad A. Massy
Masaomi Nangaku
Robert G. Nelson
Donal O'Donoghue
Ikechi Okpechi
Roberto Pecoits-Filho
Neil R. Powe
Giuseppe Remuzzi
Charlotte Roberts
Jerome Rossert
Laura Sola
Benedicte Stengel
Ernest K. Sumaili M
Yusuke Suzuki
Tetsuhiro Tanaka
Sajja Tatiyanupanwong
Bernadette Thomas
Katrin Uhlig
Robert Walker
Sarah L. White
Andrzej Wiecek
Chih-Wei Yang
KAZANCIOĞLU, RÜMEYZA
Source :
Lancet (London, England), The Lancet
Publication Year :
2016

Abstract

The global nephrology community recognises the need for a cohesive plan to address the problem of chronic kidney disease (CKD). In July, 2016, the International Society of Nephrology hosted a CKD summit of more than 85 people with diverse expertise and professional backgrounds from around the globe. The purpose was to identify and prioritise key activities for the next 5-10 years in the domains of clinical care, research, and advocacy and to create an action plan and performance framework based on ten themes: strengthen CKD surveillance; tackle major risk factors for CKD; reduce acute kidney injury-a special risk factor for CKD; enhance understanding of the genetic causes of CKD; establish better diagnostic methods in CKD; improve understanding of the natural course of CKD; assess and implement established treatment options in patients with CKD; improve management of symptoms and complications of CKD; develop novel therapeutic interventions to slow CKD progression and reduce CKD complications; and increase the quantity and quality of clinical trials in CKD. Each group produced a prioritised list of goals, activities, and a set of key deliverable objectives for each of the themes. The intended users of this action plan are clinicians, patients, scientists, industry partners, governments, and advocacy organisations. Implementation of this integrated comprehensive plan will benefit people who are at risk for or affected by CKD worldwide.

Details

ISSN :
1474547X
Volume :
390
Issue :
10105
Database :
OpenAIRE
Journal :
Lancet (London, England)
Accession number :
edsair.doi.dedup.....6f61b1644576d0e29b403bccc31cc470